Peptide dosing: mg, mcg, units, and the math that works

Key takeaways

• A milligram (mg) is a mass; a microgram (mcg) is one thousandth of a milligram; 1 mg equals 1000 mcg. This relationship is fixed and not peptide-specific.
• On a U-100 insulin syringe, 1 "unit" equals 0.01 mL of volume, so 100 units equals 1 mL. That convention was built for U-100 insulin (100 international units per mL), not for milligram-dosed peptides .
• Converting a peptide dose in milligrams to syringe units requires the post-reconstitution concentration: volume_mL = dose_mg / (mg per mL), and units = volume_mL multiplied by 100 on a U-100 syringe.
• The most-flagged dosing error in compounded GLP-1 and peptide use is reading the syringe unit marking as a count of milligrams, which the FDA has documented in compounded-product alerts including 5-fold and 10-fold overdoses .
• Labeled pen injectors (Wegovy, Ozempic, Mounjaro, Zepbound, insulin pens) skip most of this chain because the manufacturer ships a fixed concentration and the device meters the dose. Bench-reconstituted vials drawn with insulin syringes push the chain back onto the user .

Skip to:

• Three things people mix up, and what each one measures
• The math, with arbitrary numbers and no protocol implied
• U-100, U-50, and the syringe that should never be in the kit
• Why labeled pen injectors sidestep this entire problem
• Documented harm patterns, and why FDA cares
• What a defensible preparation step looks like, structurally

Three things people mix up, and what each one measures

Milligram. Microgram. Unit. These are three different kinds of measurement, and getting them confused is the single most common mistake new self-administering users make.

A milligram is a unit of mass. It tells you how much of the active ingredient is sitting in the vial. A microgram is also a unit of mass; it equals one thousandth of a milligram, so 1 mg is the same as 1000 mcg. The mg-to-mcg relationship is fixed for any substance and has nothing to do with peptides specifically. If a reference talks about "500 mcg of ipamorelin," that is the same mass as "0.5 mg of ipamorelin."

A "unit" on an insulin syringe is a volume convention, not a mass. On a U-100 syringe, 1 unit equals 0.01 mL of liquid. The label was built for U-100 insulin, where 100 international units of insulin biological activity are packed into 1 mL of liquid (hence the name "U-100") . The marking is fine for insulin because U-100 insulin always has the same concentration. The marking is dangerous for peptides because peptides do not.

The math, with arbitrary numbers and no protocol implied

Here is the entire reconstitution chain, written out with placeholder numbers. The values do not correspond to any specific peptide or labeled product. The numbers are illustrative.

1. Step 1 - Concentration. Suppose a hypothetical vial holds 5 mg of dry peptide. The user reconstitutes it with 2 mL of bacteriostatic water . The resulting concentration is 5 mg divided by 2 mL, which is 2.5 mg per mL, or equivalently 2500 mcg per mL.
2. Step 2 - Volume per dose. Suppose the planned single dose is 250 mcg. Convert 250 mcg to milligrams first: 250 mcg is 0.25 mg. Then divide the dose by the concentration: 0.25 mg divided by 2.5 mg per mL equals 0.10 mL.
3. Step 3 - Syringe units. On a U-100 insulin syringe, 1 unit equals 0.01 mL. So 0.10 mL equals 10 units. The user would draw the plunger to the 10 mark on the syringe.

Now change one variable: imagine the user reconstituted the same 5 mg vial with 1 mL of bacteriostatic water instead of 2 mL. The concentration is now 5 mg per mL, double the prior example. For the same 250 mcg dose, the draw volume is 0.05 mL, which is 5 units on a U-100 syringe. Same dose, different syringe marking. The marking is correct only with respect to the concentration the user picked at reconstitution.

Reverse the error and the consequence gets ugly. A user who thinks "draw to 10 units because the schedule said 10" without re-checking the concentration on a more concentrated vial would draw 0.10 mL of a 5 mg per mL solution, which is 0.50 mg, double the intended 0.25 mg. At the other extreme, on a 0.5 mg per mL diluted vial, drawing to 10 units would draw 0.10 mL containing 50 mcg, only one fifth of the intended dose.

U-100, U-50, and the syringe that should never be in the kit

Most insulin syringes sold in the US are U-100. A 1 mL barrel has 100 unit markings; a 0.5 mL barrel has 50 unit markings; a 0.3 mL barrel has 30 unit markings. The fluid volume per marking is 0.01 mL across the size range, and the unit count is just the label.

A U-50 syringe is also calibrated so that 1 unit equals 0.01 mL, but it is labeled 0 to 50 on a 0.5 mL barrel because it is intended for U-100 insulin doses up to 50 units. The fluid volume per marking is identical to a U-100 syringe; only the printed numbers differ.

A U-40 syringe is calibrated for U-40 veterinary insulin (40 IU per mL) and uses different fluid volume per marking. U-40 syringes should not be in a peptide kit. Mixing a U-40 syringe with a U-100-assumed math chain produces a 2.5-fold dosing error in either direction depending on which conversion the user gets wrong.

• U-100 1 mL syringe: 100 unit markings, 0.01 mL per unit, full barrel holds 1.0 mL.
• U-100 0.5 mL syringe: 50 unit markings, 0.01 mL per unit, full barrel holds 0.5 mL.
• U-100 0.3 mL syringe: 30 unit markings, 0.01 mL per unit, full barrel holds 0.3 mL.
• U-50 0.5 mL syringe: 50 unit markings, 0.01 mL per unit (numbering differs, fluid math identical).
• U-40 syringe: not interchangeable with U-100; do not use for peptide work.

Why labeled pen injectors sidestep this entire problem

Labeled GLP-1 pens (Wegovy and Ozempic semaglutide, Mounjaro and Zepbound tirzepatide) and insulin pens are designed so that the user never sees the underlying volume or concentration. The cartridge inside the pen is pre-filled at a fixed concentration by the manufacturer. The dial on the pen selects a dose in milligrams (or units of insulin) directly, and the device meters the corresponding volume internally.

That design choice eliminates the mg-to-mL conversion, the mL-to-units conversion, and the syringe-rounding step in one pass. The trade-off is that pen injectors are tied to the manufacturer's concentration schedule, so they cannot be used for compounded preparations or for peptides outside the labeled product list. Bench-reconstituted vials drawn with insulin syringes give the user full flexibility on concentration, and that flexibility is exactly where the error chain lives.

Pen injectors and bench-reconstituted vials are not interchangeable on a per-marking basis. A user moving from a Wegovy pen to a compounded semaglutide vial cannot reuse the dial marking from the pen as a syringe marking on the vial. The mg dose is the same idea on both products, but the path from "I want X mg" to "the drug actually delivered" runs through a different chain on each.

Documented harm patterns, and why FDA cares

The FDA has issued explicit alerts on dosing errors in compounded semaglutide products, including patients administering five to ten times more than the intended dose, with adverse-event reports requiring hospitalization for severe nausea, vomiting, and dehydration . The recurring failure mode in those reports is the unit-vs-milligram misread described above, layered with a concentration the patient was not clearly told and a syringe-rounding step the patient was not trained on.

Suspected dosing-error harms can be reported through the FDA MedWatch program, which collects voluntary adverse-event reports for drugs and biological products . MedWatch data is the public-health signal that drives FDA safety communications and product alerts. The broader peer-reviewed literature on parenteral medication errors describes similar concentration-mismatch and unit-handling failure modes .

What a defensible preparation step looks like, structurally

Without prescribing any specific peptide or dose, here is the structure of a self-administration prep step that controls for the high-leverage errors. The arithmetic itself is fixed; what varies is the discipline around it.

• Write the concentration on the vial at reconstitution. "5 mg per 2 mL = 2.5 mg per mL" written on tape on the vial means the math chain starts from a known anchor every time.
• Compute the draw volume and the syringe unit count once, on paper, before the first injection from the vial. Do not redo the conversion in your head at the syringe.
• Confirm the syringe type. U-100 only for human peptide work. A U-40 in the kit should be removed.
• Re-derive the math any time the vial concentration changes, including switching to a fresh vial reconstituted at a different volume.
• Cross-check with a prescriber when the prescriber is the source of the dose. The math step does not replace clinical oversight; it ensures that what reaches the body matches what the prescriber wrote.

The pepSmart Calculator at /calculator and the Dose Log at /log are educational scaffolds for the same arithmetic. The calculator turns mg, mcg, concentration, and draw volume into one consistent chain so the user does not redo the conversion at the syringe. The log records the planned and recorded dose for each scheduled day so a missed step or a wrong draw shows up in writing rather than living in memory. Neither tool is a substitute for prescriber oversight, and neither tool prescribes a dose.

Bottom line

Milligrams, micrograms, and "units" are three different things. The unit on an insulin syringe is a volume convention from the U-100 insulin world, not a mass, and not a count of milligrams. Bench-reconstituted vials push the entire mg-to-mL-to-units conversion chain back onto the user, which is exactly where the FDA dosing-error alerts and the parenteral medication-error literature locate the highest-leverage harm.

For research and educational purposes only. Not medical advice.

pepSmart has not commissioned independent clinical review of this article. Any therapeutic dosing decision, including the choice of concentration at reconstitution and the schedule the user is filling in, belongs with a qualified clinician.

For more on how this article was sourced and reviewed, see Editorial process and contributor disclosure and Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 6 entries, all primary canon (FDA, DailyMed, PubMed), last reviewed 2026-05-27.

Related tools

• GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
• GLP-1 ramp planner - Preview a linear educational dose-step table.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
• PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
• Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
• BAC water calculator - Solve BAC water volume for a target concentration.